BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8996832)

  • 1. Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease.
    McRae A; Dahlström A; Ling EA
    Gerontology; 1997; 43(1-2):95-108. PubMed ID: 8996832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease.
    McRae A; Dahlström A; Polinsky R; Ling EA
    Behav Brain Res; 1993 Nov; 57(2):225-34. PubMed ID: 8117427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial cerebrospinal fluid antibodies. Significance for Alzheimer disease.
    McRae A; Ling EA; Wigander A; Dahlström A
    Mol Chem Neuropathol; 1996; 28(1-3):89-95. PubMed ID: 8871946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies.
    Dahlström A; McRae A; Polinsky R; Nee L; Sadasivan B; Ling EA
    Mol Neurobiol; 1994; 9(1-3):41-54. PubMed ID: 7888106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mechanisms in neurodegeneration.
    Nichols MR; St-Pierre MK; Wendeln AC; Makoni NJ; Gouwens LK; Garrad EC; Sohrabi M; Neher JJ; Tremblay ME; Combs CK
    J Neurochem; 2019 Jun; 149(5):562-581. PubMed ID: 30702751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease.
    Hashemiaghdam A; Mroczek M
    J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Regen F; Hellmann-Regen J; Costantini E; Reale M
    Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system.
    McRae A; Ling EA; Polinsky R; Gottfries CG; Dahlström A
    Neuroscience; 1991; 41(2-3):739-52. PubMed ID: 1870709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicroglia antibodies in sera of Alzheimer's disease patients.
    Lemke MR; Glatzel M; Henneberg AE
    Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammatory responses in Alzheimer's disease.
    Dansokho C; Heneka MT
    J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
    Ahmad MH; Fatima M; Mondal AC
    J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process.
    McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J
    Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial dysfunction connects depression and Alzheimer's disease.
    Santos LE; Beckman D; Ferreira ST
    Brain Behav Immun; 2016 Jul; 55():151-165. PubMed ID: 26612494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial pathology in Down syndrome.
    Xue QS; Streit WJ
    Acta Neuropathol; 2011 Oct; 122(4):455-66. PubMed ID: 21847625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.
    Taylor JM; Moore Z; Minter MR; Crack PJ
    J Neural Transm (Vienna); 2018 May; 125(5):797-807. PubMed ID: 28676934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease.
    Yao K; Zu HB
    Inflammopharmacology; 2020 Feb; 28(1):95-110. PubMed ID: 31264132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study.
    Szpak GM; Lechowicz W; Lewandowska E; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Schmidt-Sidor B; Dymecki J
    Folia Neuropathol; 2001; 39(3):181-92. PubMed ID: 11770129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.
    Lombardi VR; García M; Cacabelos R
    J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation.
    Gutierrez A; Vitorica J
    J Alzheimers Dis; 2018; 64(s1):S329-S338. PubMed ID: 29562520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.